It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...


Recent comments
6 years 11 weeks ago
15 years 27 weeks ago
15 years 28 weeks ago
15 years 28 weeks ago
15 years 45 weeks ago
15 years 45 weeks ago
16 years 3 days ago
16 years 18 weeks ago
17 years 2 days ago
17 years 2 days ago